APIDRA 100 U / ML
Insuline Glulisine
Public price
366,00 MAD
Active substance
Insuline Glulisine
Laboratory
SANOFI AVENTIS MAROC
Reimbursable
What is this medicine?
APIDRA 100 U / ML: This substance is used in diabetes management. It acts on blood glucose through a mechanism that depends on the active ingredient.
Verified summary
Insuline Glulisine, Solution injectable (Retiré du marché), 3 ml, Boîte de 5 cartouches de 3 ml
Common uses
Common uses: type 2 diabetes or insulin needs, metabolic follow-up, and blood-glucose control according to patient profile. General use context: injectable or infusion form, usually used under healthcare-professional supervision.
Class
Diabetology - antidiabetic
Laboratory
SANOFI AVENTIS MAROC
Availability note
Reimbursable
Strength
3 ml
Form
Solution injectable (Retiré du marché)
Presentation
Boîte de 5 cartouches de 3 ml
Type
Princeps
Therapeutic class
Insuline humaine analogue à action rapide
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-02: 366,00 MAD
Available presentations and strengths
Medicines with the same active substance
APIDRA
100 UI / ML · BOITE DE 1 CARTOUCHE DE 3 ML
98,40 MAD
APIDRA SOLOSTAR 100 U / ML
100 U / ML, · Boîte d'un stylo pré-rempli de 3 ml
98,40 MAD
APIDRA SOLOSTAR 100 U / ML
Solution injectable [Ins]
98,40 MAD
APIDRA
100 UI / ML · BOITE DE 1 FLACON DE 10ML
235,00 MAD
APIDRA
100 UI / ML · BOITE DE 5 CARTOUCHES DE 3 ML
366,00 MAD
APIDRA SOLOSTAR 100 U / ML
3 ml · Boîte de 5 stylos pré-remplis de 3 ml
439,00 MAD